Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Renz Wolfgang has 1 pending office action in Medical Devices & Mechanical Engineering. The matter is handled by 1 distinct examiner and assigned to 1 distinct art unit, indicating a concentrated prosecution path rather than activity spread across multiple examination teams.
STIGELL, THEODORE J is the busiest examiner, with 1 pending matter. Counsel can therefore focus monitoring, technical positioning, and response planning on a single examiner relationship and one art-unit context.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GRASMEDER, SARAH DYMPNA | 1 | 72.0% | +33.7% |
| STIGELL, THEODORE J | 1 | 78.3% | +14.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18023335 | TARGETING ABNORMAL CELL POPULATIONS FOR APOPTOSIS | STIGELL, THEODORE J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18023336 | TREATING PATHOGENIC INFECTIONS | GRASMEDER, SARAH DYMPNA | 70d |
| 18023335 | TARGETING ABNORMAL CELL POPULATIONS FOR APOPTOSIS | STIGELL, THEODORE J | — |
| Art Unit | Apps |
|---|---|
| 3783 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18023336 | TREATING PATHOGENIC INFECTIONS | GRASMEDER, SARAH DYMPNA | 3783 | §103 | Non-Final OA | 70d | Pending | Feb 24, 2023 |
| 18023335 | TARGETING ABNORMAL CELL POPULATIONS FOR APOPTOSIS | STIGELL, THEODORE J | 3783 | §102§103 | Non-Final OA | — | Pending | Feb 24, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialRenz Wolfgang has 2 pending office actions as of October 2026, spread across 1 art units and 2 examiners.
Sarah Dympna Grasmeder has the most, with 1 of Renz Wolfgang's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
